Literature DB >> 9504611

Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome).

R Laskawi1, C Drobik, C Schönebeck.   

Abstract

Several therapeutic approaches exist to treat gustatory sweating (Frey's syndrome) following parotidectomy. Because of the lack of effective treatment, a new therapeutic modality using botulinum toxin injections was presented previously by our group. The duration of the demonstrated positive effect was essentially unknown so far. Based on our experiences using this technique since December 1993, the purpose of this clinical investigation was to make an up-to-date report and demonstrate the duration of effect of BOTOX injections in patients with severe gustatory sweating. Nineteen patients with severe gustatory sweating have been treated with BOTOX by intracutaneous injections into the affected skin areas. The maximal follow-up time was 33 months. The results were obtained by interviews and controls using Minor's starch iodine test. In all treated cases (n = 19 patients, 22 treated sides) gustatory sweating ceased completely within 2 days. Side effects were absent. In 12 patients gustatory sweating reappeared. The mean duration of effect was 17.3 months (subjective personal communication of 18 patients). Findings show that intracutaneous injection of BOTOX is a highly effective, safe, and minimally invasive treatment of Frey's syndrome with long-lasting therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504611     DOI: 10.1097/00005537-199803000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  23 in total

1.  [Botulinum toxin for the treatment of secretory disorders of the head and neck area].

Authors:  A Steffen
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 2.  Treatment of complications of parotid gland surgery.

Authors:  R Marchese-Ragona; C De Filippis; G Marioni; A Staffieri
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

3.  [Botulinum toxin A after microvascular ALT flap in a patient with (corrected) squamous cell carcinoma of the tongue].

Authors:  F Ihler; R Laskawi; C Matthias; H H Rustenbeck; M Canis
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

4.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

Review 5.  [Botulinum toxin in otorhinolaryngology - an update].

Authors:  R Laskawi; A Olthoff
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

Review 6.  The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.

Authors:  D A Glaser
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 7.  Botulinum toxin therapy: functional silencing of salivary disorders.

Authors:  A Lovato; D A Restivo; G Ottaviano; G Marioni; R Marchese-Ragona
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-04       Impact factor: 2.124

8.  [Unusually long latency before the appearance of Frey's syndrome after parotidectomy].

Authors:  G I Wenzel; W Draf
Journal:  HNO       Date:  2004-06       Impact factor: 1.284

9.  Histopathological and radiological investigations of the influence of botulinum toxin on the submandibular gland of the rat.

Authors:  Berna Uslu Coskun; Hayati Savk; Esin Derin Cicek; Tulay Basak; Muzaffer Basak; Burhan Dadas
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-07       Impact factor: 2.503

10.  Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis.

Authors:  Saskia Rohrbach; Katharina Junghans; Sibylle Köhler; Rainer Laskawi
Journal:  Head Face Med       Date:  2009-10-16       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.